Whitefort Capital Management, LP Arbutus Biopharma Corp Transaction History
Whitefort Capital Management, LP
- $132 Million
- Q2 2024
A detailed history of Whitefort Capital Management, LP transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Whitefort Capital Management, LP holds 12,867,967 shares of ABUS stock, worth $49.3 Million. This represents 30.08% of its overall portfolio holdings.
Number of Shares
12,867,967
Previous 12,862,152
0.05%
Holding current value
$49.3 Million
Previous $33.2 Million
19.82%
% of portfolio
30.08%
Previous 24.48%
Shares
7 transactions
Others Institutions Holding ABUS
# of Institutions
137Shares Held
95.4MCall Options Held
3.44MPut Options Held
377K-
Morgan Stanley New York, NY21MShares$80.3 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$44.2 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.57MShares$32.8 Million10.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.02MShares$26.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.31MShares$12.7 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $574M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...